RCUS 1M 7.4% Increase and then 77% Decline

Short

Arcus Biosciences, Inc. (NYSE:RCUS)

Mis à jour

NYSE:RCUS Arcus Biosciences, Inc.

Trend Analysis Beyond Technical Analysis

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Commentaire:

Measured move to $12.18 by Nov 2023

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.